[1]
|
T. J. Vulliamy, A. Marrone, S. W. Knight, et al., “Mutations in Dyskeratosis Congenita: Their Impact on Telomere Length and the Diversity of Clinical Presentation,” Blood, Vol. 107, No. 7, 2006, pp. 2680-2685.
doi:10.1182/blood-2005-07-2622
|
[2]
|
R. T. Calado and N. S.Young, “Telomere Maintenance and Human Bone Marrow Failure,” Blood, Vol. 111, No. 9, 2008, pp. 4446-4455.
doi:10.1182/blood-2007-08-019729
|
[3]
|
F. Berthet, R. Caduff, U. B. Schaad, et al., “A Syndrome of Primary Combined Immunodeficiency with Microcephaly, Cerebellar Hypoplasia, Growth Failure and Progressive Pancytopenia,” European Journal of Pediatrics, Vol. 153, No. 5, 1994, pp. 333-338.
doi:10.1007/BF01956413
|
[4]
|
I. Dokal, “Dyskeratosis Congenita,” American Society of Hematology Education Program, Vol. 2011, No. 1, 2011, pp. 480-486.
|
[5]
|
I. Dokal and T. Vulliamy, “Inherited Bone Marrow Failure Syndromes,” Haematologica, Vol. 95, No. 8, 2010, pp. 1236-1240. doi:10.3324/haematol.2010.025619
|
[6]
|
B. P. Alter, P. S. Rosenberg, N. Giri, et al., “Telomere Length Is Associated with Disease Severity and Declines with Age in Dyskeratosis Congenita,” Haematologica, Vol. 97, No. 3, 2012, pp. 353-359.
doi:10.3324/haematol.2011.055269
|
[7]
|
E. T. Valera, M. S. Brassesco, P. Roxo Jr., et al., “Genomic Instability in Hoyeraal-Hreidarsson Syndrome,” Pediatric Blood & Cancer, Vol. 54, No. 5, 2010, pp. 779-780. doi:10.1002/pbc.22446
|
[8]
|
P. Peitl, S. S. Mello, M. L. Camparoto, G. A. Passos, et al., “Chromosomal Rearrangements Involving Telomeric DNA Sequences in Balb/3T3 Cells Transfected with the Ha-ras Oncogene,” Mutagenesis, Vol. 17, No. 1, 2002, pp. 67-72. doi:10.1093/mutage/17.1.67
|
[9]
|
Y. H. Du, M. Bessler and P. J. Mason, “Telomerase Mutations and Prematures Ageing in Humans,” In: K. L. Rudolph, Telomeres and Telomerase in Ageing, Disease and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing, Springer-Verlag, Berlin, 2008, pp. 77-107.
doi:10.1007/978-3-540-73709-4_5
|
[10]
|
A. Marrone and P. J. Mason, “Dyskeratosis Congenita,” Cellular and Molecular Life Sciences, Vol. 60, 2003, pp. 507-517.
|
[11]
|
A. Marrone, A. Walne, H. Tamary, et al., “Telomerase Reverse-Transcriptase Homozygous Mutations in Autosomal Recessive Dyskeratosis Congenita and Hoyeraal-Hreidarsson Syndrome,” Blood, Vol. 110, No. 13, 2007, pp. 4198-4205. doi:10.1182/blood-2006-12-062851
|
[12]
|
H. Yamaguchi, R. T. Calado, H. Ly, et al., “Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia,” New England Journal of Medicine, Vol. 352, 2005, pp. 1413-1424. doi:10.1056/NEJMoa042980
|
[13]
|
S. A. Savage and A. A. Bertuch, “The Genetics and Clinical Manifestations of Telomere Biology Disorders,” Genetics in Medicine, Vol. 12, No. 12, 2010, pp. 753-764.
|
[14]
|
A. J. Walne, T. Vulliamy, A. Marrone, et al., “Genetic Heterogeneity in Autosomal Recessive Dyskeratosis Congenita with One Subtype Due to Mutations in the Telomerase-Associated Protein NOP10,” Human Molecular Genetics, Vol. 16, No. 13, 2007, pp. 1619-1629.
doi:10.1093/hmg/ddm111
|
[15]
|
T. Vulliamy, R. Beswick, M. Kirwan, A. Marrone, et al., “Mutations in the Telomerase Component NHP2 Cause the Premature Ageing Syndrome Dyskeratosis Congenital,” Proceedings of the National Academy Sciences of the USA, Vol. 105, No. 23, 2008, pp. 8073-8078.
doi:10.1073/pnas.0800042105
|
[16]
|
S. A. Savage, N. Giri, G. M. Baerlocher, et al., “TINF2, a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenital,” American Journal of Human Genetics, Vol. 82, No. 2, 2008, pp. 501-509. doi:10.1016/j.ajhg.2007.10.004
|
[17]
|
F. Touzot, I. Callebaut, J. Soulier, et al., “Function of Apollo (SNM1B) at Telomere Highlighted by a Splice Variant Identified in a Patient with Hoyeraal-Hreidarsson Syndrome,” Proceedings of the National Academy Sciences of the USA, Vol. 107, No. 22, 2010, pp. 10097-10102. doi:10.1073/pnas.0914918107
|
[18]
|
T. J. Vulliamy, S. W. Knight, P. J. Mason and I. Dokal, “Very Short Telomeres in the Peripheral Blood of Patients with X-Linked and Autosomal Dyskeratosis Congenital,” Blood Cells, Molecules, and Diseases, Vol. 27, No. 2, 2001, pp. 353-357. doi:10.1006/bcmd.2001.0389
|
[19]
|
B. P. Alter, G. M. Baerlocher, S. A. Savage, et al., “Very Short Telomere Length by Flow Fluorescence in Situ Hybridization Identifies Patients with Dyskeratosis Congenital,” Blood, Vol. 110, No. 5, 2007, pp. 1439-1447.
doi:10.1182/blood-2007-02-075598
|
[20]
|
N. Lamm, E. Ordan, R. Shponkin, et al., “Diminished Telomeric 3’Overhangs Are Associated with Telomere Dysfunction in Hoyeraal-Hreidarsson Syndrome,” PLoS One, Vol. 4, No. 5, 2009, p. e5666.
doi:10.1371/journal.pone.0005666
|